quick FAQ since the cellular reprogramming headlines are kicking off another round of “where can i buy MOTS-c” DMs to anyone who’s posted about peptides in the last six months. trying to answer the questions people actually keep asking, not the ones the marketing wants you to ask. “is this the same thing as the longevity peptides being sold online?” no. partial epigenetic reprogramming via OSKM or chemical cocktails is a completely different mechanism from anything in a compounding vial. MOTS-c, humanin, epitalon, SS-31 are not reprogramming factors. they’re mitochondrial-derived or pineal peptides with their own (much smaller) evidence base. conflating them is how vendors will sell you a $400 stack on the back of a press release that has nothing to do with what’s in the vial. “is it legal to compound the longevity peptides right now?” depends on the molecule and the framework. 503A facilities can compound for a specific patient with a valid Rx, but the molecule has to be on the FDA bulks list or otherwise compliant with section 503A(b). a lot of the longevity peptides aren’t. epitalon, for example, is not on the 503A bulks list. selling it as “compounded” is a stretch under the statute, regardless of what the website says. “is it safe?” different question. illegal, unsafe, and ill-advised aren’t the same thing, and people on these threads tend to collapse them. a peptide that fails the regulatory framework can still be relatively benign in the short term, and a fully legal compounded preparation can still hurt you badly if the sterility was bad. two questions to ask separately: is the pharmacy actually a 503A or 503B with current FDA registration, and have they got third-party CoAs for sterility, endotoxin, and potency on the specific lot you’re getting. if the answer is hand-waved, walk away. “what about the human trial that’s about to start?” a write-up I read described it as a phase 1 safety design, which is what you do when you have no human safety data yet. that’s the whole point of phase 1, it tells you whether the intervention causes acute harm at the doses you’re testing. it does not tell you whether it reverses aging. expect the readout to be safety endpoints and maybe biomarker movement, not lifespan or healthspan. “so what should I actually do with the news?” bookmark it, watch the readout, don’t preorder anything. the compounded version of this won’t exist for years if it ever does, and anyone offering you a “reprogramming peptide stack” right now is selling something else under a borrowed headline.